Featured Publications
Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans : A Target Trial Emulation.
Ioannou G, Berry K, Rajeevan N, Li Y, Mutalik P, Yan L, Bui D, Cunningham F, Hynes D, Rowneki M, Bohnert A, Boyko E, Iwashyna T, Maciejewski M, Osborne T, Viglianti E, Aslan M, Huang G, Bajema K. Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans : A Target Trial Emulation. Annals Of Internal Medicine 2023, 176: 1486-1497. PMID: 37903369, PMCID: PMC10620954, DOI: 10.7326/m23-1394.Peer-Reviewed Original ResearchMeSH KeywordsAgedAntiviral AgentsCOVID-19COVID-19 Drug TreatmentFemaleHumansMaleRetrospective StudiesRitonavirSARS-CoV-2ThromboembolismUnited StatesVeteransConceptsAcute COVID-19Veterans Health AdministrationUntreated comparatorsThromboembolic eventsCOVID-19Severe COVID-19Target trial emulationSARS-CoV-2Post COVID-19 conditionIndex dateVenous thromboembolismBaseline characteristicsCumulative incidencePulmonary embolismAcute infectionMedian ageOral antiviralsTrial emulationVHA careOutpatient treatmentInternational ClassificationHealth AdministrationU.S. veteransVeterans AffairsOrgan systems
2024
Changes in Outpatient Health Care Use After COVID-19 Infection Among Veterans
Hebert P, Kumbier K, Smith V, Hynes D, Govier D, Wong E, Kaufman B, Shepherd-Banigan M, Rowneki M, Bohnert A, Ioannou G, Boyko E, Iwashyna T, O’Hare A, Bowling C, Viglianti E, Maciejewski M, Admon A, Akgun K, Anderson L, Anderson S, Aslan M, Au D, Backus L, Bajema K, Baraff A, Batten L, Berkowitz T, Bernstein T, Berry Wyatt K, Bogdan J, Borgerding J, Bosworth H, Boucher N, Burwick N, Byrd K, Cabrales A, Cano J, Chai W, Chen J, Cheung K, Crothers K, Cummin G, Curtis J, Davis M, Del Monico E, Dennis P, Dobalian A, Doll J, Dominitz J, Eastment M, Fan V, Ferguson J, Floyd B, Fox A, Goetz M, Green P, Hastings S, Hauschildt K, Hawkins E, Helfand M, Hickok A, Horowitz D, Hough C, Hu E, Ikuta K, Jones B, Jones M, Kamphius L, Knight S, Korpak A, Korpela P, Langa K, Laundry R, Lavin S, Li Y, Lindquist J, McCready H, Meyer C, Michel M, Miles A, Milne J, Monahan M, Morelli D, Mutalik P, Naylor J, Niederhausen M, Newell S, Nugent S, Ong M, Osborne T, Peterson M, Peterson A, Prescott H, Pura J, Rajeevan N, Reddy A, Rouse M, Saha S, Saini S, Seelye S, Shah J, Shahoumian T, Shaukat A, Showalter W, Slatore C, Smith B, Smith N, Streja E, Suri P, Sussman J, Takata Y, Teo A, Thomas E, Thomas L, Tuepker A, Turner A, Veigulis Z, Vig E, Vranas K, Wang X, Wicks K, Winchell K, Womer J, Woods C, Wysham K, Yan L, Zulman D. Changes in Outpatient Health Care Use After COVID-19 Infection Among Veterans. JAMA Network Open 2024, 7: e2355387. PMID: 38334995, PMCID: PMC10858406, DOI: 10.1001/jamanetworkopen.2023.55387.Peer-Reviewed Original ResearchMeSH KeywordsAgedCOVID-19HumansMaleMedicareMiddle AgedOutpatientsRetrospective StudiesTelemedicineUnited StatesVeteransConceptsOutpatient health care useHealth care useCare useOutpatient useOutpatient visitsPrimary care visitsCounts of outpatient visitsPrimary care patientsOutpatient care utilizationCategories of careVeterans Affairs Corporate Data WarehouseCorporate Data WarehouseIncreased outpatient visitsNegative binomial regression modelsBinomial regression modelsCare visitsCare utilizationPopulation surveillance studyRetrospective cohort studyCare patientsUninfected veteransCOVID-19 infectionMain OutcomesPeri-infection periodCohort study
2023
Metformin prescription for U.S. veterans with prediabetes, 2010–2019
Gulanski B, Goulet J, Radhakrishnan K, Ko J, Li Y, Rajeevan N, Lee K, Heberer K, Lynch J, Streja E, Mutalik P, Cheung K, Concato J, Shih M, Lee J, Aslan M. Metformin prescription for U.S. veterans with prediabetes, 2010–2019. Journal Of Investigative Medicine 2023, 72: 139-150. PMID: 37668313, DOI: 10.1177/10815589231201141.Peer-Reviewed Original ResearchConceptsBody mass indexVeterans Health AdministrationIncident prediabetesHigh riskHealth AdministrationRetrospective observational cohort studyType 2 diabetes mellitusUse of metforminObservational cohort studyProportion of veteransMetformin prescribingGestational diabetesCohort studyMetformin prescriptionDiabetes mellitusDiabetes preventionMass indexCardiovascular diseaseMultivariable modelPrediabetesSubset of individualsMetforminU.S. veteransHealthcare systemVeteransEffectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes
Bajema K, Berry K, Streja E, Rajeevan N, Li Y, Mutalik P, Yan L, Cunningham F, Hynes D, Rowneki M, Bohnert A, Boyko E, Iwashyna T, Maciejewski M, Osborne T, Viglianti E, Aslan M, Huang G, Ioannou G. Effectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes. Annals Of Internal Medicine 2023, 176: m22-3565. PMID: 37276589, PMCID: PMC10243488, DOI: 10.7326/m22-3565.Peer-Reviewed Original ResearchMeSH KeywordsAgedAntiviral AgentsCOVID-19COVID-19 Drug TreatmentCOVID-19 VaccinesFemaleHumansMaleRetrospective StudiesRitonavirSARS-CoV-2VeteransConceptsVeterans Health AdministrationCOVID-19 symptom onsetCOVID-19-related outcomesSevere COVID-19Six-month outcomesCOVID-19 vaccinationCOVID-19 treatmentCOVID-19SARS-CoV-2Percent of participantsUntreated control participantsCause mortalitySymptom onsetMedian ageOral antiviralsVHA careOutpatient treatmentHospitalizationHealth AdministrationDay 31U.S. veteransVariant transmissionMost veteransVeterans AffairsOne month